Amgen, VC groups pump $16.5M into Sutro Biopharma

Sutro Biopharma has reeled in more capital to back work on next-generation protein drugs. Skyline Ventures led the second $16.5 million closing of the San Francisco-based startup's Series C round, whi…
Read the full story: News